BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kato H, Fukuchi M, Miyazaki T, Nakajima M, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Manda R, Ojima H, Tsukada K, Oriuchi N, Endo K, Kuwano H. Positron emission tomography in esophageal cancer. Esophagus 2005;2:111-21. [DOI: 10.1007/s10388-005-0053-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Sekiguchi M, Terauchi T, Kakugawa Y, Shimada N, Saito Y, Matsuda T. Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. World J Gastroenterol 2017; 23(15): 2743-2749 [PMID: 28487611 DOI: 10.3748/wjg.v23.i15.2743] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Kato H, Nakajima M, Sohda M, Tanaka N, Inose T, Miyazaki T, Fukuchi M, Oriuchi N, Endo K, Kuwano H. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer. 2009;115:3196-3203. [PMID: 19472406 DOI: 10.1002/cncr.24399] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
3 Tanabe S, Naomoto Y, Shirakawa Y, Fujiwara Y, Sakurama K, Noma K, Takaoka M, Yamatsuji T, Hiraki T, Okumura Y. F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma. Clin Nucl Med. 2011;36:854-859. [PMID: 21892033 DOI: 10.1097/RLU.0b013e318217adc9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]